Fortress Biotech Pref Preferred Stock Performance
| FBIOP Preferred Stock | USD 11.11 0.20 1.77% |
On a scale of 0 to 100, Fortress Biotech holds a performance score of 15. The firm shows a Beta (market volatility) of 0.29, which means not very significant fluctuations relative to the market. As returns on the market increase, Fortress Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Fortress Biotech is expected to be smaller as well. Please check Fortress Biotech's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Fortress Biotech's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech Pref are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Fortress Biotech reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 235 M | |
| Total Cashflows From Investing Activities | 40.5 M |
Fortress |
Fortress Biotech Relative Risk vs. Return Landscape
If you would invest 669.00 in Fortress Biotech Pref on November 17, 2025 and sell it today you would earn a total of 442.00 from holding Fortress Biotech Pref or generate 66.07% return on investment over 90 days. Fortress Biotech Pref is currently producing 0.9219% returns and takes up 4.7565% volatility of returns over 90 trading days. Put another way, 42% of traded preferred stocks are less volatile than Fortress, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Fortress Biotech Target Price Odds to finish over Current Price
The tendency of Fortress Preferred Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 11.11 | 90 days | 11.11 | about 24.25 |
Based on a normal probability distribution, the odds of Fortress Biotech to move above the current price in 90 days from now is about 24.25 (This Fortress Biotech Pref probability density function shows the probability of Fortress Preferred Stock to fall within a particular range of prices over 90 days) .
Fortress Biotech Price Density |
| Price |
Predictive Modules for Fortress Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fortress Biotech Pref. Regardless of method or technology, however, to accurately forecast the preferred stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the preferred stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Fortress Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fortress Biotech is not an exception. The market had few large corrections towards the Fortress Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fortress Biotech Pref, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fortress Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.85 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 2.22 | |
Ir | Information ratio | 0.17 |
Fortress Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fortress Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fortress Biotech Pref can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fortress Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. |
Fortress Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fortress Preferred Stock often depends not only on the future outlook of the current and potential Fortress Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fortress Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 66 M | |
| Cash And Short Term Investments | 305.7 M |
Fortress Biotech Fundamentals Growth
Fortress Preferred Stock prices reflect investors' perceptions of the future prospects and financial health of Fortress Biotech, and Fortress Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fortress Preferred Stock performance.
| Return On Equity | -1.43 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (2.63) % | ||||
| Current Valuation | 2.58 B | ||||
| Shares Outstanding | 56.68 M | ||||
| Price To Sales | 1.36 X | ||||
| Revenue | 68.79 M | ||||
| EBITDA | (46.05 M) | ||||
| Cash And Equivalents | 248.77 M | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 46.56 M | ||||
| Debt To Equity | 0.81 % | ||||
| Book Value Per Share | 0.57 X | ||||
| Cash Flow From Operations | (116.54 M) | ||||
| Earnings Per Share | (0.86) X | ||||
| Total Asset | 396.5 M | ||||
About Fortress Biotech Performance
Assessing Fortress Biotech's fundamental ratios provides investors with valuable insights into Fortress Biotech's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fortress Biotech is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.Things to note about Fortress Biotech Pref performance evaluation
Checking the ongoing alerts about Fortress Biotech for important developments is a great way to find new opportunities for your next move. Preferred Stock alerts and notifications screener for Fortress Biotech Pref help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fortress Biotech appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. |
- Analyzing Fortress Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fortress Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Fortress Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fortress Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fortress Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fortress Biotech's preferred stock. These opinions can provide insight into Fortress Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.